Company intelligence / Profile preview
Apeiron Research Center
Vienna, Vienna, Austria
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Apeiron Biologics is a European biotechnology company focused on developing innovative immunotherapies for cancer and respiratory diseases. Founded by Dr. Josef Penninger, the company successfully developed and brought to market Qarziba (dinutuximab beta) for the treatment of high-risk neuroblastoma, which was subsequently sold to EUSA Pharma. Apeiron's current clinical focus includes APN01, a recombinant human angiotensin-converting enzyme 2 (rhACE2) for respiratory conditions such as ARDS and COVID-19. In 2022, the company restructured its immuno-oncology activities into a new entity called invIOs, while maintaining its corporate presence in Vienna, Austria.
- Therapeutic areas
- OncologyCardiovascularPulmonologyInfectious Diseases
- Modalities
- Recombinant proteinCell therapySmall moleculeMonoclonal antibodysiRNA
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
EUSA PharmaGlaxoSmithKline
Beyond the preview
Go deeper on Apeiron Research Center.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apeiron Research Center.